Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients stop using the treatment within a few weeks or months. A recent study compared adverse health outcomes following buprenorphine discontinuation among patients who were successfully retained beyond 6 months of continued treatment.

https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.19060612